J 2023

Impact of PFAS exposure on prevalence of immune-mediated diseases in adults in the Czech Republic

RUDZANOVÁ, Barbora, Jelle VLAANDEREN, Jiří KALINA, Pavel PILER, Martin ZVONAŘ et. al.

Basic information

Original name

Impact of PFAS exposure on prevalence of immune-mediated diseases in adults in the Czech Republic

Authors

RUDZANOVÁ, Barbora (203 Czech Republic, belonging to the institution), Jelle VLAANDEREN, Jiří KALINA (203 Czech Republic, belonging to the institution), Pavel PILER (203 Czech Republic, belonging to the institution), Martin ZVONAŘ (203 Czech Republic, belonging to the institution), Jana KLÁNOVÁ (203 Czech Republic, belonging to the institution), Luděk BLÁHA (203 Czech Republic, belonging to the institution) and Ondřej ADAMOVSKÝ (203 Czech Republic, guarantor, belonging to the institution)

Edition

Environmental Research, Elsevier, 2023, 0013-9351

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10511 Environmental sciences

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 8.300 in 2022

RIV identification code

RIV/00216224:14310/23:00131221

Organization unit

Faculty of Science

UT WoS

000992616900001

Keywords in English

Perfluoroalkyl substances; Immune system; Adult cohort; Allergy; Eczema; Bayesian kernel machine regression

Tags

Tags

International impact, Reviewed
Změněno: 8/3/2024 22:14, Mgr. Michaela Hylsová, Ph.D.

Abstract

V originále

Background: Per-and polyfluoroalkyl substances (PFASs) are emerging environmental contaminants with mul-tiple hazardous properties including immunomodulation potency. Human exposure to PFASs has been associated with various immune-mediated diseases and outcomes. This study aimed to investigate the association between PFAS exposure and immune-mediated diseases such as allergies, eczemas, and autoimmune diseases in a pop-ulation of adults in the Czech Republic.Methods: This study included 309 adults from the Central European Longitudinal Study of Parents and Children: Young Adults (CELSPAC: YA). 12 PFASs were measured in participants' serum by HPLC-MS/MS, 3 PFASs were removed from the subsequent analyses due to low detection frequency. The associations of 9 PFASs with 9 immune-mediated diseases were assessed by logistic regression. Furthermore, Bayesian kernel machine regres-sion (BKMR) was used to estimate the effect of the PFAS mixture on immune-mediated diseases. All analyses were adjusted for sex, age, BMI, smoking, education, and family history of immune-mediated diseases. In cases of a statistically significant interaction of PFASs and sex, stratified analyses were performed for men and women.Results: Perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) were negatively associated with both atopic eczema (OR per IQR increase 0.58 (95% CI 0.37-0.90) for PFOA and 0.56 (0.32-0.95) for PFOS) and contact dermatitis (0.37 (0.16-0.85) for PFOA and 0.33 (0.11-0.94) for PFOS). Perfluoroundecanoate (PFUnDA) was negatively associated with pollen, dust, and mite allergy (0.62 (0.43-0.89)). BKMR modelling showed a negative tendency in the overall effect of PFAS mixture on immune-health outcomes. Based on the stratified analysis, sex was suggested to be an effect modifier in the association of PFOS and atopic eczema.Conclusion: Our results contribute to the body of literature that observes the immunosuppressive effect of PFAS exposure during eczemas and allergies, both for PFASs individually and as a mixture.

Links

EF15_003/0000469, research and development project
Name: Cetocoen Plus
EF17_043/0009632, research and development project
Name: CETOCOEN Excellence
857560, interní kód MU
(CEP code: EF17_043/0009632)
Name: CETOCOEN Excellence (Acronym: CETOCOEN Excellence)
Investor: European Union, Spreading excellence and widening participation
90121, large research infrastructures
Name: RECETOX RI